Label Changes for:
Lyrica (pregabalin) Capsules and Oral Solution
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2011 and August 2011
- Gynecomastia and breast enlargement
What is the most important information I should know about Lyrica
- section revised to furnish adequate information for the safe and effective use of the drug